{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T03:30:27Z","timestamp":1783135827640,"version":"3.54.6"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T00:00:00Z","timestamp":1502928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T00:00:00Z","timestamp":1502928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mass administration of endectocides, drugs that kill blood-feeding arthropods, has been proposed as a complementary strategy to reduce malaria transmission. Ivermectin is one of the leading candidates given its excellent safety profile. Here we provide proof that the effect of ivermectin can be boosted at two different levels by drugs inhibiting the cytochrome or ABC transporter in the mammal host and the target mosquitoes. Using a mini-pig model, we show that drug-mediated cytochrome P450\/ABC transporter inhibition results in a 3-fold increase in the time ivermectin remains above mosquito-killing concentrations. In contrast, P450\/ABC transporter induction with rifampicin markedly impaired ivermectin absorption. The same ketoconazole-mediated cytochrome\/ABC transporter inhibition also occurs outside the mammal host and enhances the mortality of <jats:italic>Anopheles gambiae<\/jats:italic>. This was proven by using the samples from the mini-pig experiments to conduct an <jats:italic>ex-vivo<\/jats:italic> synergistic bioassay by membrane-feeding <jats:italic>Anopheles<\/jats:italic> mosquitoes. Inhibiting the same cytochrome\/xenobiotic pump complex in two different organisms to simultaneously boost the pharmacokinetic and pharmacodynamic activity of a drug is a novel concept that could be applied to other systems. Although the lack of a dose-response effect in the synergistic bioassay warrants further exploration, our study may have broad implications for the control of parasitic and vector-borne diseases.<\/jats:p>","DOI":"10.1038\/s41598-017-08906-x","type":"journal-article","created":{"date-parts":[[2017,8,11]],"date-time":"2017-08-11T10:29:28Z","timestamp":1502447368000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Cytochrome P450\/ABC transporter inhibition simultaneously enhances ivermectin pharmacokinetics in the mammal host and pharmacodynamics in Anopheles gambiae"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9812-050X","authenticated-orcid":false,"given":"Carlos J.","family":"Chaccour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Hammann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Alustiza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Castejon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian B.","family":"Tarimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Abizanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel","family":"Irigoyen Barrio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Mart\u00ed Soler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Moncada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Ignacio","family":"Bilbao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azucena","family":"Aldaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Maia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Del Pozo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,17]]},"reference":[{"key":"8906_CR1","unstructured":"WHO. World Malaria report 2016. http:\/\/www.who.int\/entity\/malaria\/publications\/world-malaria-report-2016\/report\/en\/index.html (Accessed Jan 2017). (Geneva, World Health Organization, 2016)."},{"key":"8906_CR2","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nature15535","volume":"526","author":"S Bhatt","year":"2015","unstructured":"Bhatt, S. et al. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature \n                           526, 207\u2013211, doi:10.1038\/nature15535 (2015).","journal-title":"Nature"},{"key":"8906_CR3","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.pt.2015.11.010","volume":"32","author":"H Ranson","year":"2016","unstructured":"Ranson, H. & Lissenden, N. Insecticide Resistance in African Anopheles Mosquitoes: A Worsening Situation that Needs Urgent Action to Maintain Malaria Control. Trends Parasitol \n                           32, 187\u2013196, doi:10.1016\/j.pt.2015.11.010 (2016).","journal-title":"Trends Parasitol"},{"key":"8906_CR4","doi-asserted-by":"publisher","first-page":"809","DOI":"10.4269\/ajtmh.13-0065","volume":"88","author":"GF Killeen","year":"2013","unstructured":"Killeen, G. F. A second chance to tackle African malaria vector mosquitoes that avoid houses and don\u2019t take drugs. Am J Trop Med Hyg \n                           88, 809\u2013816, doi:10.4269\/ajtmh.13-0065 (2013).","journal-title":"Am J Trop Med Hyg"},{"key":"8906_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-13-330","volume":"13","author":"GFC Killeen","year":"2014","unstructured":"Killeen, G. F. C. controlling and eliminating residual malaria transmission. Malar J \n                           13, 330, doi:10.1186\/1475-2875-13-330 (2014).","journal-title":"Malar J"},{"key":"8906_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-12-153","volume":"12","author":"CJ Chaccour","year":"2013","unstructured":"Chaccour, C. J. et al. Ivermectin to reduce malaria transmission: a research agenda for a promising new tool for elimination. Malar J \n                           12, 153, doi:10.1186\/1475-2875-12-153 (2013).","journal-title":"Malar J"},{"key":"8906_CR7","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.pt.2011.05.007","volume":"27","author":"BD Foy","year":"2011","unstructured":"Foy, B. D., Kobylinski, K. C., da Silva, I. M., Rasgon, J. L. & Sylla, M. Endectocides for malaria control. Trends Parasitol \n                           27, 423\u2013428 (2011).","journal-title":"Trends Parasitol"},{"key":"8906_CR8","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aag2374","volume":"8","author":"AM Bellinger","year":"2016","unstructured":"Bellinger, A. M. et al. Oral, ultra-long-lasting drug delivery: Application toward malaria elimination goals. Sci Transl Med \n                           8, 365ra157, doi:10.1126\/scitranslmed.aag2374 (2016).","journal-title":"Sci Transl Med"},{"key":"8906_CR9","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1093\/infdis\/jiu351","volume":"210","author":"HC Slater","year":"2014","unstructured":"Slater, H. C., Walker, P. G., Bousema, T., Okell, L. C. & Ghani, A. C. The potential impact of adding ivermectin to a mass treatment intervention to reduce malaria transmission: a modelling study. J Infect Dis \n                           210, 1972\u20131980, doi:10.1093\/infdis\/jiu351 (2014).","journal-title":"J Infect Dis"},{"key":"8906_CR10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1086\/653208","volume":"202","author":"C Chaccour","year":"2010","unstructured":"Chaccour, C., Lines, J. & Whitty, C. J. Effect of ivermectin on Anopheles gambiae mosquitoes fed on humans: the potential of oral insecticides in malaria control. J Infect Dis \n                           202, 113\u2013116 (2010).","journal-title":"J Infect Dis"},{"key":"8906_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-13-417","volume":"13","author":"H Alout","year":"2014","unstructured":"Alout, H. et al. Evaluation of ivermectin mass drug administration for malaria transmission control across different West African environments. Malar J \n                           13, 417, doi:10.1186\/1475-2875-13-417 (2014).","journal-title":"Malar J"},{"key":"8906_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-9-365","volume":"9","author":"M Sylla","year":"2010","unstructured":"Sylla, M. et al. Mass drug administration of ivermectin in south-eastern Senegal reduces the survivorship of wild-caught, blood fed malaria vectors. Malar J \n                           9, 365 (2010).","journal-title":"Malar J"},{"key":"8906_CR13","unstructured":"Mectizan Donation Program. Annual highlights 2015. http:\/\/www.mectizan.org\/sites\/www.mectizan.org\/files\/attachments\/resources\/MDP_AnnHigh2015_Design%20041516FINAL2%20%281%29.pdf (Accessed August 2016)."},{"key":"8906_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002219.pub2","volume":"8","author":"HO Ejere","year":"2012","unstructured":"Ejere, H. O., Schwartz, E., Wormald, R. & Evans, J. R. Ivermectin for onchocercal eye disease (river blindness). The Cochrane database of systematic reviews \n                           8, CD002219, doi:10.1002\/14651858.CD002219.pub2 (2012).","journal-title":"The Cochrane database of systematic reviews"},{"key":"8906_CR15","unstructured":"Merck & Co. Stromectrol. FDA approved Package insert 2009. http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/050742s026lbl.pdf (Accessed October, 2016)."},{"key":"8906_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-016-1540-y","volume":"15","author":"VS Sampaio","year":"2016","unstructured":"Sampaio, V. S. et al. Filling gaps on ivermectin knowledge: effects on the survival and reproduction of Anopheles aquasalis, a Latin American malaria vector. Malar J \n                           15, 491, doi:10.1186\/s12936-016-1540-y (2016).","journal-title":"Malar J"},{"key":"8906_CR17","doi-asserted-by":"publisher","DOI":"10.2196\/resprot.6617","volume":"5","author":"MR Smit","year":"2016","unstructured":"Smit, M. R. et al. Efficacy and Safety of High-Dose Ivermectin for Reducing Malaria Transmission (IVERMAL): Protocol for a Double-Blind, Randomized, Placebo-Controlled, Dose-Finding Trial in Western Kenya. JMIR Res Protoc \n                           5, e213, doi:10.2196\/resprot.6617 (2016).","journal-title":"JMIR Res Protoc"},{"key":"8906_CR18","unstructured":"Foy, B. D. Results from RIMDAMAL, a pilot randomized cluster-design trial in Burkina Faso, designed to assess the safety and efficacy of repeat ivermectin mass drug administrations to control malaria and NTDs. Oral presentation during the 65th Annual Meeting of the ASTMH. Atlanta 2016."},{"key":"8906_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-015-0618-2","volume":"14","author":"C Chaccour","year":"2015","unstructured":"Chaccour, C. et al. Screening for an ivermectin slow-release formulation suitable for malaria vector control. Malar J \n                           14, 102, doi:10.1186\/s12936-015-0618-2 (2015).","journal-title":"Malar J"},{"key":"8906_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-017-1801-4","volume":"16","author":"C Chaccour","year":"2017","unstructured":"Chaccour, C., Hammann, F. & Rabinovich, N. R. Ivermectin to reduce malaria transmission I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safety. Malar J \n                           16, 161, doi:10.1186\/s12936-017-1801-4 (2017).","journal-title":"Malar J"},{"key":"8906_CR21","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s40262-014-0167-9","volume":"53","author":"KB Larson","year":"2014","unstructured":"Larson, K. B., Wang, K., Delille, C., Otofokun, I. & Acosta, E. P. Pharmacokinetic enhancers in HIV therapeutics. Clin Pharmacokinet \n                           53, 865\u2013872, doi:10.1007\/s40262-014-0167-9 (2014).","journal-title":"Clin Pharmacokinet"},{"key":"8906_CR22","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1080\/004982598239597","volume":"28","author":"Z Zeng","year":"1998","unstructured":"Zeng, Z., Andrew, N. W., Arison, B. H., Luffer-Atlas, D. & Wang, R. W. Identification of cytochrome P4503A4 as the major enzyme responsible for the metabolism of ivermectin by human liver microsomes. Xenobiotica; the fate of foreign compounds in biological systems \n                           28, 313\u2013321, doi:10.1080\/004982598239597 (1998).","journal-title":"Xenobiotica; the fate of foreign compounds in biological systems"},{"key":"8906_CR23","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1042\/bse0500161","volume":"50","author":"FJ Sharom","year":"2011","unstructured":"Sharom, F. J. The P-glycoprotein multidrug transporter. Essays Biochem \n                           50, 161\u2013178, doi:10.1042\/bse0500161 (2011).","journal-title":"Essays Biochem"},{"key":"8906_CR24","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.pharmthera.2006.04.009","volume":"112","author":"I Cascorbi","year":"2006","unstructured":"Cascorbi, I. Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs. Pharmacol Ther \n                           112, 457\u2013473, doi:10.1016\/j.pharmthera.2006.04.009 (2006).","journal-title":"Pharmacol Ther"},{"key":"8906_CR25","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0169-409X(02)00006-6","volume":"54","author":"TR Stouch","year":"2002","unstructured":"Stouch, T. R. & Gudmundsson, O. Progress in understanding the structure-activity relationships of P-glycoprotein. Advanced drug delivery reviews \n                           54, 315\u2013328 (2002).","journal-title":"Advanced drug delivery reviews"},{"key":"8906_CR26","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.cbpa.2006.06.015","volume":"10","author":"MV Varma","year":"2006","unstructured":"Varma, M. V., Perumal, O. P. & Panchagnula, R. Functional role of P-glycoprotein in limiting peroral drug absorption: optimizing drug delivery. Curr Opin Chem Biol \n                           10, 367\u2013373, doi:10.1016\/j.cbpa.2006.06.015 (2006).","journal-title":"Curr Opin Chem Biol"},{"key":"8906_CR27","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1124\/dmd.113.056176","volume":"42","author":"R Callaghan","year":"2014","unstructured":"Callaghan, R., Luk, F. & Bebawy, M. Inhibition of the multidrug resistance P-glycoprotein: time for a change of strategy? Drug Metab Dispos \n                           42, 623\u2013631, doi:10.1124\/dmd.113.056176 (2014).","journal-title":"Drug Metab Dispos"},{"key":"8906_CR28","doi-asserted-by":"publisher","first-page":"326","DOI":"10.2174\/15680096113139990076","volume":"13","author":"Z Binkhathlan","year":"2013","unstructured":"Binkhathlan, Z. & Lavasanifar, A. P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives. Curr Cancer Drug Targets \n                           13, 326\u2013346 (2013).","journal-title":"Curr Cancer Drug Targets"},{"key":"8906_CR29","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1097\/00001813-199609000-00005","volume":"7","author":"A Didier","year":"1996","unstructured":"Didier, A. & Loor, F. The abamectin derivative ivermectin is a potent P-glycoprotein inhibitor. Anticancer Drugs \n                           7, 745\u2013751 (1996).","journal-title":"Anticancer Drugs"},{"key":"8906_CR30","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/0092-8674(94)90212-7","volume":"77","author":"AH Schinkel","year":"1994","unstructured":"Schinkel, A. H. et al. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell \n                           77, 491\u2013502 (1994).","journal-title":"Cell"},{"key":"8906_CR31","doi-asserted-by":"crossref","unstructured":"Mealey, K. L., Bentjen, S. A., Gay, J. M. & Cantor, G. H. Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene. Pharmacogenetics \n                           11, 727\u2013733 (2001).","DOI":"10.1097\/00008571-200111000-00012"},{"key":"8906_CR32","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4269\/ajtmh.2010.09-0734","volume":"83","author":"C Bourguinat","year":"2010","unstructured":"Bourguinat, C. et al. Analysis of the mdr-1 gene in patients co-infected with Onchocerca volvulus and Loa loa who experienced a post-ivermectin serious adverse event. Am J Trop Med Hyg \n                           83, 28\u201332, doi:10.4269\/ajtmh.2010.09-0734 (2010).","journal-title":"Am J Trop Med Hyg"},{"key":"8906_CR33","doi-asserted-by":"publisher","unstructured":"Edwards, G. Ivermectin: does P-glycoprotein play a role in neurotoxicity? Filaria J \n                           2 Suppl 1, S8, doi:10.1186\/1475-2883-2-S1-S8 (2003).","DOI":"10.1186\/1475-2883-2-S1-S8"},{"key":"8906_CR34","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1038\/bjc.2014.222","volume":"110","author":"JJ Hendrikx","year":"2014","unstructured":"Hendrikx, J. J. et al. Oral co-administration of elacridar and ritonavir enhances plasma levels of oral paclitaxel and docetaxel without affecting relative brain accumulation. Br J Cancer \n                           110, 2669\u20132676, doi:10.1038\/bjc.2014.222 (2014).","journal-title":"Br J Cancer"},{"key":"8906_CR35","first-page":"311","volume":"10","author":"C Hugnet","year":"2007","unstructured":"Hugnet, C., Lespine, A. & Alvinerie, M. Multiple oral dosing of ketoconazole increases dog exposure to ivermectin. Journal of pharmacy & pharmaceutical sciences: a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques \n                           10, 311\u2013318 (2007).","journal-title":"Journal of pharmacy & pharmaceutical sciences: a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques"},{"key":"8906_CR36","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.vetpar.2008.06.017","volume":"157","author":"M Alvinerie","year":"2008","unstructured":"Alvinerie, M., Dupuy, J., Kiki-Mvouaka, S., Sutra, J. F. & Lespine, A. Ketoconazole increases the plasma levels of ivermectin in sheep. Veterinary parasitology \n                           157, 117\u2013122, doi:10.1016\/j.vetpar.2008.06.017 (2008).","journal-title":"Veterinary parasitology"},{"key":"8906_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0027760","volume":"6","author":"R Djouaka","year":"2011","unstructured":"Djouaka, R., Irving, H., Tukur, Z. & Wondji, C. S. Exploring mechanisms of multiple insecticide resistance in a population of the malaria vector Anopheles funestus in Benin. PloS one \n                           6, e27760, doi:10.1371\/journal.pone.0027760 (2011).","journal-title":"PloS one"},{"key":"8906_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0110058","volume":"9","author":"C Mulamba","year":"2014","unstructured":"Mulamba, C. et al. Widespread pyrethroid and DDT resistance in the major malaria vector Anopheles funestus in East Africa is driven by metabolic resistance mechanisms. PloS one \n                           9, e110058, doi:10.1371\/journal.pone.0110058 (2014).","journal-title":"PloS one"},{"key":"8906_CR39","doi-asserted-by":"crossref","unstructured":"Deus, K. M., Saavedra-Rodriguez, K., Butters, M. P., Black, W. C. t. & Foy, B. D. The effect of ivermectin in seven strains of Aedes aegypti (Diptera: Culicidae) including a genetically diverse laboratory strain and three permethrin resistant strains. J Med Entomol \n                           49, 356\u2013363 (2012).","DOI":"10.1603\/ME11164"},{"key":"8906_CR40","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.150231","volume":"6","author":"LP Chen","year":"2016","unstructured":"Chen, L. P., Wang, P., Sun, Y. J. & Wu, Y. J. Direct interaction of avermectin with epidermal growth factor receptor mediates the penetration resistance in Drosophila larvae. Open Biol \n                           6, 150231, doi:10.1098\/rsob.150231 (2016).","journal-title":"Open Biol"},{"key":"8906_CR41","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/imb.12204","volume":"25","author":"X Wang","year":"2016","unstructured":"Wang, X. et al. A point mutation in the glutamate-gated chloride channel of Plutella xylostella is associated with resistance to abamectin. Insect Mol Biol \n                           25, 116\u2013125, doi:10.1111\/imb.12204 (2016).","journal-title":"Insect Mol Biol"},{"key":"8906_CR42","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.ibmb.2013.04.006","volume":"43","author":"L Luo","year":"2013","unstructured":"Luo, L., Sun, Y. J. & Wu, Y. J. Abamectin resistance in Drosophila is related to increased expression of P-glycoprotein via the dEGFR and dAkt pathways. Insect Biochem Mol Biol \n                           43, 627\u2013634, doi:10.1016\/j.ibmb.2013.04.006 (2013).","journal-title":"Insect Biochem Mol Biol"},{"key":"8906_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-016-1497-2","volume":"9","author":"C Mangia","year":"2016","unstructured":"Mangia, C. et al. Evaluation of the in vitro expression of ATP binding-cassette (ABC) proteins in an Ixodes ricinus cell line exposed to ivermectin. Parasit Vectors \n                           9, 215, doi:10.1186\/s13071-016-1497-2 (2016).","journal-title":"Parasit Vectors"},{"key":"8906_CR44","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/j.1365-2583.2011.01097.x","volume":"20","author":"KS Yoon","year":"2011","unstructured":"Yoon, K. S. et al. Brief exposures of human body lice to sublethal amounts of ivermectin over-transcribes detoxification genes involved in tolerance. Insect Mol Biol \n                           20, 687\u2013699, doi:10.1111\/j.1365-2583.2011.01097.x (2011).","journal-title":"Insect Mol Biol"},{"key":"8906_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17030274","volume":"17","author":"X Gao","year":"2016","unstructured":"Gao, X. et al. Identification and Characterization of the Gene CYP340W1 from Plutella xylostella and Its Possible Involvement in Resistance to Abamectin. Int J Mol Sci \n                           17, 274, doi:10.3390\/ijms17030274 (2016).","journal-title":"Int J Mol Sci"},{"key":"8906_CR46","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.actatropica.2013.10.020","volume":"130","author":"M Chouaibou","year":"2014","unstructured":"Chouaibou, M., Zivanovic, G. B., Knox, T. B., Jamet, H. P. & Bonfoh, B. Synergist bioassays: A simple method for initial metabolic resistance investigation of field Anopheles gambiae s.l. populations. Acta Trop \n                           130, 108\u2013111, doi:10.1016\/j.actatropica.2013.10.020 (2014).","journal-title":"Acta Trop"},{"key":"8906_CR47","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/00498250802638155","volume":"39","author":"ES Perloff","year":"2009","unstructured":"Perloff, E. S. et al. Validation of cytochrome P450 time-dependent inhibition assays: a two-time point IC50 shift approach facilitates kinact assay design. Xenobiotica; the fate of foreign compounds in biological systems \n                           39, 99\u2013112, doi:10.1080\/00498250802638155 (2009).","journal-title":"Xenobiotica; the fate of foreign compounds in biological systems"},{"key":"8906_CR48","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1128\/AAC.46.1.160-165.2002","volume":"46","author":"EJ Wang","year":"2002","unstructured":"Wang, E. J., Lew, K., Casciano, C. N., Clement, R. P. & Johnson, W. W. Interaction of common azole antifungals with P glycoprotein. Antimicrobial agents and chemotherapy \n                           46, 160\u2013165 (2002).","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"8906_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/1476-0711-5-3","volume":"5","author":"J Chen","year":"2006","unstructured":"Chen, J. & Raymond, K. Roles of rifampicin in drug-drug interactions: underlying molecular mechanisms involving the nuclear pregnane X receptor. Ann Clin Microbiol Antimicrob \n                           5, 3, doi:10.1186\/1476-0711-5-3 (2006).","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"8906_CR50","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/cid\/ciu797","volume":"60","author":"AL Ouedraogo","year":"2015","unstructured":"Ouedraogo, A. L. et al. Efficacy and safety of the mosquitocidal drug ivermectin to prevent malaria transmission after treatment: a double-blind, randomized, clinical trial. Clin Infect Dis \n                           60, 357\u2013365, doi:10.1093\/cid\/ciu797 (2015).","journal-title":"Clin Infect Dis"},{"key":"8906_CR51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0042821","volume":"7","author":"T Bousema","year":"2012","unstructured":"Bousema, T. et al. Mosquito feeding assays to determine the infectiousness of naturally infected Plasmodium falciparum gametocyte carriers. PloS one \n                           7, e42821, doi:10.1371\/journal.pone.0042821 (2012).","journal-title":"PloS one"},{"key":"8906_CR52","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/biomet\/91.2.263","volume":"91","author":"RE Gangnon","year":"2004","unstructured":"Gangnon, R. E. & Kosorok, M. R. Sample\u2010size formula for clustered survival data using weighted log\u2010rank statistics. Biometrika \n                           91, 263\u2013275, doi:10.1093\/biomet\/91.2.263 (2004).","journal-title":"Biometrika"},{"key":"8906_CR53","doi-asserted-by":"crossref","unstructured":"Chiu, S. H. & Lu, A. Y. in W.C. Campbell (ed), Ivermectin and Abamectin 131\u2013143 (Springer-Verlag, 1989).","DOI":"10.1007\/978-1-4612-3626-9_8"},{"key":"8906_CR54","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1046\/j.1365-2885.1999.00172.x","volume":"22","author":"A Lifschitz","year":"1999","unstructured":"Lifschitz, A. et al. Bioequivalence of ivermectin formulations in pigs and cattle. J Vet Pharmacol Ther \n                           22, 27\u201334 (1999).","journal-title":"J Vet Pharmacol Ther"},{"key":"8906_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6921","volume":"6","author":"M Gendrin","year":"2015","unstructured":"Gendrin, M. et al. Antibiotics in ingested human blood affect the mosquito microbiota and capacity to transmit malaria. Nature communications \n                           6, 5921, doi:10.1038\/ncomms6921 (2015).","journal-title":"Nature communications"},{"key":"8906_CR56","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1016\/j.clinthera.2015.07.022","volume":"37","author":"EM Sherman","year":"2015","unstructured":"Sherman, E. M., Worley, M. V., Unger, N. R., Gauthier, T. P. & Schafer, J. J. Cobicistat: Review of a Pharmacokinetic Enhancer for HIV Infection. Clin Ther \n                           37, 1876\u20131893, doi:10.1016\/j.clinthera.2015.07.022 (2015).","journal-title":"Clin Ther"},{"key":"8906_CR57","volume":"58","author":"I Carmichael","year":"1987","unstructured":"Carmichael, I., Visser, R., Schneider, D. & Soll, M. Haemonchus contortus resistance to ivermectin. Journal of the South African Veterinary Association \n                           58, 93 (1987).","journal-title":"Journal of the South African Veterinary Association"},{"key":"8906_CR58","doi-asserted-by":"publisher","first-page":"614","DOI":"10.2307\/3282179","volume":"74","author":"JR Egerton","year":"1988","unstructured":"Egerton, J. R., Suhayda, D. & Eary, C. H. Laboratory selection of Haemonchus contortus for resistance to ivermectin. The Journal of parasitology \n                           74, 614\u2013617 (1988).","journal-title":"The Journal of parasitology"},{"key":"8906_CR59","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/BF01958163","volume":"47","author":"JG Scott","year":"1991","unstructured":"Scott, J. G., Roush, R. T. & Liu, N. Selection of high-level abamectin resistance from field-collected house flies. Musca domestica. Experientia \n                           47, 288\u2013291 (1991).","journal-title":"Musca domestica. Experientia"},{"key":"8906_CR60","volume":"149","author":"JR Martins","year":"2001","unstructured":"Martins, J. R. & Furlong, J. Avermectin resistance of the cattle tick Boophilus microplus in Brazil. Vet Rec \n                           149, 64 (2001).","journal-title":"Vet Rec"},{"key":"8906_CR61","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1086\/421776","volume":"39","author":"BJ Currie","year":"2004","unstructured":"Currie, B. J., Harumal, P., McKinnon, M. & Walton, S. F. First documentation of in vivo and in vitro ivermectin resistance in Sarcoptes scabiei. Clin Infect Dis \n                           39, e8\u201312, doi:10.1086\/421776 (2004).","journal-title":"Clin Infect Dis"},{"key":"8906_CR62","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/0169-4758(93)90136-4","volume":"9","author":"WL Shoop","year":"1993","unstructured":"Shoop, W. L. Ivermectin resistance. Parasitol Today \n                           9, 154\u2013159 (1993).","journal-title":"Parasitol Today"},{"key":"8906_CR63","unstructured":"Escobedo-Vargas, K. S. et al. The effect of ivermectin on the Amazonian malaria vector Anopheles darlingi: LC50 determination. Poster session presentes at the 65thAnnual meeting of the American Society of Tropical Medicine and Hygiene; 2016 Nov 11\u201316; Atlanta, USA. (2016)."},{"key":"8906_CR64","unstructured":"Kobylinski, K. et al. Assessing ivermectin susceptibility of Greater Mekong Subregion malaria vectors. Poster session presentes at: Annual meeting of the American Society of Tropical Medicine and Hygiene; 2014 Nov 2\u20136; New Orleans, USA."},{"key":"8906_CR65","unstructured":"Kobylinski, K. et al. Mosquito-lethal efficacy of ivermectin, dihydroartemisinin-piperaquine, and primaquine: Ivermectin for Malaria in Southeast Asia (IMSEA Study). Oral presentation during the 65th Annual Meeting of the ASTMH. Atlanta 2016 (2016)."},{"key":"8906_CR66","unstructured":"Smit, M., Ochomo, E. & ter Kuile, F. Efficacy and safety of high-dose ivermectin for reducing malaria transmission: A dose finding study (IVERMAL). Oral presentation during the 65th Annual Meeting of the ASTMH. Atlanta 2016."},{"key":"8906_CR67","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3109\/03602538708998309","volume":"18","author":"SH Chiu","year":"1987","unstructured":"Chiu, S. H., Taub, R., Sestokas, E., Lu, A. Y. & Jacob, T. A. Comparative in vivo and in vitro metabolism of ivermectin in steers, sheep, swine, and rat. Drug Metab Rev \n                           18, 289\u2013302, doi:10.3109\/03602538708998309 (1987).","journal-title":"Drug Metab Rev"},{"key":"8906_CR68","doi-asserted-by":"publisher","first-page":"P94","DOI":"10.1016\/S0009-9236(03)90702-8","volume":"73","author":"SR Vanapalli","year":"2003","unstructured":"Vanapalli, S. R. et al. Orange juice decreases the oral bioavailability of ivermectin in healthy volunteers. Clinical Pharmacology & Therapeutics \n                           73, P94\u2013P94, doi:10.1016\/S0009-9236(03)90702-8 (2003).","journal-title":"Clinical Pharmacology & Therapeutics"},{"key":"8906_CR69","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/sj.clpt.6100056","volume":"81","author":"H Glaeser","year":"2007","unstructured":"Glaeser, H. et al. Intestinal drug transporter expression and the impact of grapefruit juice in humans. Clin Pharmacol Ther \n                           81, 362\u2013370, doi:10.1038\/sj.clpt.6100056 (2007).","journal-title":"Clin Pharmacol Ther"},{"key":"8906_CR70","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1124\/dmd.113.051052","volume":"41","author":"T Imaoka","year":"2013","unstructured":"Imaoka, T. et al. Integrated approach of in vivo and in vitro evaluation of the involvement of hepatic uptake organic anion transporters in the drug disposition in rats using rifampicin as an inhibitor. Drug Metab Dispos \n                           41, 1442\u20131449, doi:10.1124\/dmd.113.051052 (2013).","journal-title":"Drug Metab Dispos"},{"key":"8906_CR71","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1517\/17425255.2014.894020","volume":"10","author":"C Dandara","year":"2014","unstructured":"Dandara, C., Swart, M., Mpeta, B., Wonkam, A. & Masimirembwa, C. Cytochrome P450 pharmacogenetics in African populations: implications for public health. Expert Opin Drug Metab Toxicol \n                           10, 769\u2013785, doi:10.1517\/17425255.2014.894020 (2014).","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"8906_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2350-11-111","volume":"11","author":"W Kudzi","year":"2010","unstructured":"Kudzi, W., Dodoo, A. N. & Mills, J. J. Genetic polymorphisms in MDR1, CYP3A4 and CYP3A5 genes in a Ghanaian population: a plausible explanation for altered metabolism of ivermectin in humans? BMC Med Genet \n                           11, 111, doi:10.1186\/1471-2350-11-111 (2010).","journal-title":"BMC Med Genet"},{"key":"8906_CR73","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.pt.2008.03.011","volume":"24","author":"A Lespine","year":"2008","unstructured":"Lespine, A., Alvinerie, M., Vercruysse, J., Prichard, R. K. & Geldhof, P. ABC transporter modulation: a strategy to enhance the activity of macrocyclic lactone anthelmintics. Trends Parasitol \n                           24, 293\u2013298, doi:10.1016\/j.pt.2008.03.011 (2008).","journal-title":"Trends Parasitol"},{"key":"8906_CR74","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ijpddr.2011.10.001","volume":"2","author":"A Lespine","year":"2012","unstructured":"Lespine, A., Menez, C., Bourguinat, C. & Prichard, R. K. P-glycoproteins and other multidrug resistance transporters in the pharmacology of anthelmintics: Prospects for reversing transport-dependent anthelmintic resistance. International journal for parasitology. Drugs and drug resistance \n                           2, 58\u201375, doi:10.1016\/j.ijpddr.2011.10.001 (2012).","journal-title":"Drugs and drug resistance"},{"key":"8906_CR75","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1017\/S003118200999148X","volume":"137","author":"C Devine","year":"2010","unstructured":"Devine, C. et al. Inhibition of cytochrome P450-mediated metabolism enhances ex vivo susceptibility of Fasciola hepatica to triclabendazole. Parasitology \n                           137, 871\u2013880, doi:10.1017\/S003118200999148X (2010).","journal-title":"Parasitology"},{"key":"8906_CR76","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/S0020-7519(02)00130-3","volume":"32","author":"J Morales-Montor","year":"2002","unstructured":"Morales-Montor, J., Hallal-Calleros, C., Romano, M. C. & Damian, R. T. Inhibition of p-450 aromatase prevents feminisation and induces protection during cysticercosis. Int J Parasitol \n                           32, 1379\u20131387 (2002).","journal-title":"Int J Parasitol"},{"key":"8906_CR77","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3347\/kjp.2013.51.2.165","volume":"51","author":"SH Seif El-Din","year":"2013","unstructured":"Seif El-Din, S. H., Abdel-Aal Sabra, A. N., Hammam, O. A. & El-Lakkany, N. M. Effect of ketoconazole, a cytochrome P450 inhibitor, on the efficacy of quinine and halofantrine against Schistosoma mansoni in mice. Korean J Parasitol \n                           51, 165\u2013175, doi:10.3347\/kjp.2013.51.2.165 (2013).","journal-title":"Korean J Parasitol"},{"key":"8906_CR78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004279","volume":"9","author":"PD Ziniel","year":"2015","unstructured":"Ziniel, P. D. et al. The Schistosoma mansoni Cytochrome P450 (CYP3050A1) Is Essential for Worm Survival and Egg Development. PLoS Negl Trop Dis \n                           9, e0004279, doi:10.1371\/journal.pntd.0004279 (2015).","journal-title":"PLoS Negl Trop Dis"},{"key":"8906_CR79","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1093\/jme\/tju025","volume":"52","author":"MA Alegria-Lopez","year":"2015","unstructured":"Alegria-Lopez, M. A., Rodriguez-Vivas, R. I., Torres-Acosta, J. F., Ojeda-Chi, M. M. & Rosado-Aguilar, J. A. Use of Ivermectin as Endoparasiticide in Tropical Cattle Herds Generates Resistance in Gastrointestinal Nematodes and the Tick Rhipicephalus microplus (Acari: Ixodidae). J Med Entomol \n                           52, 214\u2013221, doi:10.1093\/jme\/tju025 (2015).","journal-title":"J Med Entomol"},{"key":"8906_CR80","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0006-2952(97)00432-2","volume":"55","author":"A Wong","year":"1998","unstructured":"Wong, A. & Bandiera, S. M. Induction of hepatic cytochrome P450 2B and P450 3A isozymes in rats by zolazepam, a constituent of Telazol. Biochem Pharmacol \n                           55, 201\u2013207 (1998).","journal-title":"Biochem Pharmacol"},{"key":"8906_CR81","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jneumeth.2013.03.006","volume":"216","author":"J Pleticha","year":"2013","unstructured":"Pleticha, J. et al. Pig lumbar spine anatomy and imaging-guided lateral lumbar puncture: a new large animal model for intrathecal drug delivery. J Neurosci Methods \n                           216, 10\u201315, doi:10.1016\/j.jneumeth.2013.03.006 (2013).","journal-title":"J Neurosci Methods"},{"key":"8906_CR82","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/BF01839011","volume":"16","author":"EW Scott","year":"1992","unstructured":"Scott, E. W. & McKellar, Q. A. The distribution and some pharmacokinetic parameters of ivermectin in pigs. Veterinary research communications \n                           16, 139\u2013146 (1992).","journal-title":"Veterinary research communications"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-08906-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-08906-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-08906-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T08:41:14Z","timestamp":1671784874000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-08906-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,17]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["8906"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-08906-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,17]]},"assertion":[{"value":"16 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"8535"}}